| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/10/2010 | EP2161262A1 THCV and THCV extracts derived from plant material |
| 03/10/2010 | EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 03/10/2010 | EP2161252A1 N-Alkylcarbonyl-amino acid ester and N-Alkylcarbonyl-amino lactone compounds and their use |
| 03/10/2010 | EP2161024A1 Combination product for the treatment of cancer |
| 03/10/2010 | EP2161023A2 Anti-angiogenic agents and methods of use. |
| 03/10/2010 | EP2161022A1 Production of phosphate connectors and phosphate connectors produced according to the method |
| 03/10/2010 | EP2160466A1 Treatment and prevention of influenza |
| 03/10/2010 | EP2160465A1 Tumour growth inhibitory compounds and methods of their use |
| 03/10/2010 | EP2160396A2 Thiocarbon-protecting groups for rna synthesis |
| 03/10/2010 | EP2160394A1 Tenofovir disoproxil hemi-fumaric acid co-crystal |
| 03/10/2010 | EP2160393A1 Novel compounds as cannabinoid receptor ligands |
| 03/10/2010 | EP2160392A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/10/2010 | EP2160390A1 Novel process |
| 03/10/2010 | EP2160387A2 Heteroarylamide pyrimidone compounds |
| 03/10/2010 | EP2160386A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds |
| 03/10/2010 | EP2160385A1 2-substituted isoflavonoid compounds, medicaments and uses |
| 03/10/2010 | EP2160381A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 03/10/2010 | EP2160380A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors |
| 03/10/2010 | EP2160377A1 Targeting diazo prodrugs for the treatment of gastrointestinal diseases |
| 03/10/2010 | EP2160195A1 Novel muscle relaxant using negative charge gold nanoparticle with choline |
| 03/10/2010 | EP2160193A1 Furanone copolymers |
| 03/10/2010 | EP2160192A1 Antimicrobial materials and coatings |
| 03/10/2010 | EP2160191A1 Suppression of viruses involved in respiratory infection or disease |
| 03/10/2010 | EP2160190A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
| 03/10/2010 | EP2160187A1 Spiroindalones |
| 03/10/2010 | EP2160186A2 Creatine compositions for skin treatment |
| 03/10/2010 | EP2160184A2 Hypercompressed particles for controlled release of ophthalmic medications |
| 03/10/2010 | EP2160183A1 Extended release formulations comprising quetipine and methods for their manufacture |
| 03/10/2010 | EP2160182A1 Formulations and methods for treating dry eye |
| 03/10/2010 | EP2029558B1 Compounds and methods for modulating fxr |
| 03/10/2010 | EP2027122B1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 03/10/2010 | EP2013166B1 N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use |
| 03/10/2010 | EP1973425B1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 03/10/2010 | EP1951235B1 Novel crystal forms of irinotecan hydrochloride |
| 03/10/2010 | EP1863818B1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| 03/10/2010 | EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands |
| 03/10/2010 | EP1841423B1 Use of 1- benzyl-1- hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino propionic acid amides and related compounds as analgesics |
| 03/10/2010 | EP1828182B1 Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 03/10/2010 | EP1807420B1 Trisubstituted thiophenes as progesterone receptor modulators |
| 03/10/2010 | EP1786801B1 2-arylcarbamoyl-indoles as cytokine inhibitors |
| 03/10/2010 | EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 03/10/2010 | EP1765816B1 Substituted 1-propiolylpiperazines having an affinity for the mglur5 receptor in order to treat painful conditions |
| 03/10/2010 | EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/10/2010 | EP1745031B1 Crystalline forms of duloxetine free base |
| 03/10/2010 | EP1715865B1 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid |
| 03/10/2010 | EP1713510B1 Growth factor-binding compounds attached to a calixarene |
| 03/10/2010 | EP1682541B1 Method for producing tiotropium salts |
| 03/10/2010 | EP1651628B1 Antibiotic compound |
| 03/10/2010 | EP1554586B1 Identification of drugs against mycobacteria |
| 03/10/2010 | EP1511752B3 Camptothecins with a modified lactone ring |
| 03/10/2010 | EP1460998B1 Extended release pharmaceutical tablet of metformin |
| 03/10/2010 | EP1423376B1 Bicyclic compound, production and use thereof |
| 03/10/2010 | EP1377293B1 Aryl and biaryl piperidines used as mch antagonists |
| 03/10/2010 | EP1313699B1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 03/10/2010 | EP1030663B1 Treatment of fibromyalgia and related disorders |
| 03/10/2010 | EP1023315B1 Methods and compositions for destruction of selected proteins |
| 03/10/2010 | EP0980363B1 Preparation of isoflavones from legumes |
| 03/10/2010 | EP0932678B2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/10/2010 | EP0830146B1 Methods of inducing immune tolerance using immunotoxins |
| 03/10/2010 | CN101668532A Method of treating vitamin d insufficiency and deficiency |
| 03/10/2010 | CN101668531A Combination therapy for treatment of immune disorders |
| 03/10/2010 | CN101668530A methods of activating irs-1 and akt |
| 03/10/2010 | CN101668529A Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 03/10/2010 | CN101668528A Compounds and methods for treatment of hcv |
| 03/10/2010 | CN101668527A pharmaceutical formulation |
| 03/10/2010 | CN101668526A A novel use of antidepressant compounds and related compositions |
| 03/10/2010 | CN101668525A New use of glutaminyl cyclase inhibitors |
| 03/10/2010 | CN101668524A Pyrazole derivatives as 11-beta-hsd1 inhibitors |
| 03/10/2010 | CN101668523A An anti-diabetic extract of honeybush |
| 03/10/2010 | CN101668522A Composition and method for binding acetaldehyde in stomach |
| 03/10/2010 | CN101668521A New combination for use in the treatment of inflammatory disorders |
| 03/10/2010 | CN101668520A Methods for the treatment of liver diseases |
| 03/10/2010 | CN101664554A Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor |
| 03/10/2010 | CN101664418A Application of Sarcopyramis nepalensis Wall polysaccharide for preparing anti-HBV medicine |
| 03/10/2010 | CN101664417A Niclofolan-contained compound sustained-release animal parasiticide |
| 03/10/2010 | CN101664416A Application of astragaloside in treating delayed type hypersensitivity mediated diseases |
| 03/10/2010 | CN101664415A Injection used for treating dog colibacillus infection and preparation method thereof |
| 03/10/2010 | CN101664414A Combination of brimonidine and timolol for topical ophthalmic use |
| 03/10/2010 | CN101664413A Medicinal health agent for preventing and treating canine/feline magnesium ammonium phosphate stones |
| 03/10/2010 | CN101664412A Medicinal health agent for preventing and treating canine uric acid calculi |
| 03/10/2010 | CN101664411A Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative |
| 03/10/2010 | CN101664410A Medicine composition of rosiglitazone and amiloride and application thereof |
| 03/10/2010 | CN101664409A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/10/2010 | CN101664408A Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/10/2010 | CN101664407A Pharmaceutical composition for treating angiocardiopathy |
| 03/10/2010 | CN101664406A Composition for treating and/or preventing gastric ulcer and use thereof |
| 03/10/2010 | CN101664405A New application of albendazole |
| 03/10/2010 | CN101664404A Fragrant solomonseal rhizome isoflavanone extract as well as preparation method and application thereof |
| 03/10/2010 | CN101664403A Medicinal composition for treating cancer and signal transduction path thereof |
| 03/10/2010 | CN101664402A Ginkgo flavone and tea polyphenol combined anti-radiation medicament |
| 03/10/2010 | CN101664401A Application of usnic acid in preparation of drugs inhibiting angiogenesis |
| 03/10/2010 | CN101664400A Application of salvianolic acid B to preparation of medicament for treating tumor |
| 03/10/2010 | CN101664399A Application of perillene in preparing antibacterial drugs |
| 03/10/2010 | CN101664398A Application of perillene in preparing drugs with function of promoting intestinal peristalsis and combination |
| 03/10/2010 | CN101664397A Application of high-purity EPA-E and DHA polyenoic acid ethyl ester in preparation of nutritional supplement for patients in operative period |
| 03/10/2010 | CN100593543C Hemin production process |
| 03/10/2010 | CN100593539C Malonamide derivatives blocking the activtiy of gamma-secretase |
| 03/10/2010 | CN100593405C External preparation of Fexofenadine |
| 03/10/2010 | CN100593404C Ketorolac tromethamine freezing-dried power injection and preparation method thereof |
| 03/10/2010 | CN100593403C Oxiracetam preparation and method of preparing the same |